[No-reflow phenomenon in the practice of an endovascular surgeon]

Area of Science:

• Cardiology
• Interventional Cardiology

Background:

• The no-reflow phenomenon is a significant complication following percutaneous coronary intervention (PCI).
• It is characterized by the absence of distal coronary artery filling despite successful epicardial artery reperfusion.
• The primary cause is the distal embolization of atheromatous and thrombotic material.

Purpose of the Study:

• To review the classifications for evaluating myocardial and coronary reperfusion in the context of no-reflow.
• To discuss management strategies, including pharmacological and mechanical interventions.

Main Methods:

• Literature review of studies on no-reflow phenomenon.
• Analysis of different classification systems for reperfusion.
• Discussion of therapeutic options.

Main Results:

• Several classifications exist for assessing myocardial and coronary reperfusion.
• Aspiration catheters and glycoprotein IIb/IIIa inhibitors are among the discussed interventions.
• Various pharmacological agents can influence patient prognosis.

Conclusions:

• Effective management of the no-reflow phenomenon requires understanding its causes and available therapeutic options.
• Further research into optimal treatment strategies is warranted to improve patient outcomes.